SCHEMBL1824941

SCHEMBL1824941

COC(=O)C(c1cccc(OS(=O)(=O)c2ccc(C)cc2)c1)C(N)C(=O)OCC1c2ccccc2-c2ccccc21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.38
GAA P10253 1/20 0.38
G6PD P11413 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
GPR17 Q13304 2/20 0.37
PLAU P00749 1/20 0.37
PLAT P00750 1/20 0.37
DHODH Q02127 1/20 0.37
EPHX2 P34913 1/20 0.36
ALDH1A1 P00352 3/20 0.36
BMP1 P13497 1/20 0.35
KMT2A Q03164 2/20 0.35
CASP3 P42574 2/20 0.35
LMNA P02545 2/20 0.35
ENPP2 Q13822 1/20 0.35
HPGD P15428 1/20 0.35
P2RY2 P41231 1/20 0.35
MAOB P27338 1/20 0.34
DRD2 P14416 1/20 0.34
DRD1 P21728 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1825579 0.94 CASP3 (0.40) EPHX2KMT2ACASP3
SCHEMBL1823491 0.93 DHODH (0.37) MAPTGAAG6PDNPSR1GPR17
SCHEMBL1824563 0.91 GPR17 (0.36) MAPTGAAG6PDNPSR1GPR17
SCHEMBL1821643 0.91 ENPP2 (0.38) MAPTDHODHALDH1A1BMP1KMT2A
SCHEMBL1826700 0.91 P2RX7 (0.36) MAPTGAAG6PDNPSR1GPR17
SCHEMBL1823539 0.90 P2RX7 (0.39) MAPTGAAG6PDNPSR1DHODH
SCHEMBL1822423 0.88 CASP3 (0.35) MAPTGAAG6PDNPSR1GPR17
SCHEMBL1824362 0.88 CASP3 (0.37) GAAEPHX2ALDH1A1KMT2ACASP3
SCHEMBL1821787 0.87 CASP3 (0.40) EPHX2KMT2ACASP3
SCHEMBL1824575 0.85 CASP3 (0.37) PLAUPLATEPHX2KMT2ACASP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2161254-B1 Intermediate for preparing a biaryl compound SUMITOMO CHEMICAL CO (JP) 2014-08-13 EP disclosed
EP-1481967-B1 PROCESS FOR THE PREPARATION OF BIARYL COMPOUNDS SUMITOMO CHEMICAL CO (JP) 2011-05-04 EP disclosed
US-7714157-B2 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-05-11 US disclosed
EP-2161254-A1 Intermediate for preparing a biaryl compound Sumitomo Chemical Company, Limited (JP) 2010-03-10 EP disclosed
US-20070270603-A1 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED 2007-11-22 US disclosed
US-7271280-B2 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-09-18 US disclosed
EP-1481967-A1 PROCESS FOR THE PREPARATION OF BIARYL COMPOUNDS Sumitomo Chemical Company, Limited (JP) 2004-12-01 EP disclosed
US-20040158093-A1 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED 2004-08-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040158093-A1 Process for preparing a biaryl compound CYP1B1, REL, CYP2F1 MAPT 4712/4885GAA 2170/4885G6PD 2532/4885
US-20070270603-A1 Process for preparing a biaryl compound CYP4A11, CYP4B1, CYP51A1 MAPT 2237/4885GAA 98/4885G6PD 3528/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.